Autonomy Ventures

Autonomy Ventures is a New York-based early-stage venture capital fund founded in 2016 by Oliver Mitchell, Gary Lubin, and Lynn Greenberg. Lubin previously served as a founding member of Merck Capital Ventures, a $100 million-plus medical devices and healthcare IT fund, while Greenberg joined from Bloomberg — together giving the partnership depth across financial services and health technology. The firm focuses on seed and Series A investments in artificial intelligence, robotics, IoT, and smart device technologies. Autonomy has made 27 investments across the United States and Israel, including Angular Finance, Bumper, and Ingress-Health in sectors spanning fintech, mobility, and healthcare. Checks typically range from $500,000 to $3 million, deployed into companies building business products and services across AI, cybersecurity, SaaS, advanced manufacturing, infrastructure, and machine learning. The dual geography — US and Israel — reflects the partners' recognition that Israel's deep tech talent pool produces particularly strong companies in AI and security. The firm's thesis centers on the convergence of artificial intelligence, robotics, and connected devices — technologies that are increasingly embedded in industrial, commercial, and consumer contexts. Autonomy invests at the point where these technologies are moving from proof-of-concept to early commercial adoption, a stage where capital and strategic guidance can accelerate meaningful scale. The combination of financial services expertise from Lubin, media and data experience from Greenberg, and Oliver Mitchell's founding partnership creates a team with broad perspectives on how intelligent systems create enterprise value.